Ticker Symbol: ITCI

Intra-Cellular Therapies Inc

$40.86 - 20-12-2024 4 p.m. ET

Exchange: NASDAQ Country: US Currency: USD Asset Type: Common Stock CIK:0001567514

Company Profile

Intra-Cellular Therapies is a biopharmaceutical company founded on Nobel prize-winning research that allows us to understand how therapies affect the inner-workings of cells in the body. The company leverages this intracellular approach to develop innovative treatments for people living with complex psychiatric and neurologic diseases.

Sector: Manufacturing

Industry: Pharmaceutical Preparation Manufacturing

Standard Industrial Classification Code (SIC code): 2834

Address: 430 E 29th St

Website: www.intracellulartherapies.com

CEO: Sharon Mates

Tags:

Health Technology
Biotechnology
Manufacturing
Pharmaceutical Preparation Manufacturing

Pricing

Last Updated: October 3, 2023 03:00 PM EST

Previous Close: $51.49

Change: -$1.00 ( -1.91%)

Days Range: $51.18 - $52.93

Beta: 0.59

52wk. High: $67.05

52wk. Low: $42.01

Ytd. Change -2.72%

50 Day Moving Average: $54.25

200 Day Moving Average: $59.51

Shares Outstanding: 95925601

Valuation

Market Cap: 493.9B

PE Ratio: -

EPS (TTM): 0

Dividends

Dividend Per Share (TTM): -

Dividend Yield (TTM): 0.00%

Ex-Dividend Date: N/A